Skip to main content

Table 1 Association of 14-3-3σ expression with patient's characteristics in primary gastric cancer

From: Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Variable All cases Training set (n = 66) Testing set (n = 86)
   High
expression
Low
expression
p a High
expression
Low
expression
p a
Age (years)        
≥ 58.00 b 83 25(30.1%) 13(15.7%) 0.627 29(34.9%) 16(19.3%) 0.010
< 58.00 69 20(29.0%) 8(11.6%)   15(21.7%) 26(37.7%)  
Gender        
Male 105 29(27.6%) 16(15.2%) 0.340 31(29.5%) 29(27.6%) 0.887
Female 47 16(34.0%) 5(10.6%)   13(27.7%) 13(27.7%)  
Clinical stage        
I + II 45 6(13.3%) 12(26.7%) 0.000 6(13.3%) 21(46.7%) 0.000
III + IV 107 39(36.4%) 9(8.4%)   38(35.5%) 21(19.6%)  
Tumor invasion        
T1+T2 23 0(0%) 7(30.4%) 0.000 3(13.0%) 13(56.5%) 0.005
T3+T4 129 45(34.9%) 14(10.9%)   41(31.8%) 29(22.5%)  
Node stage        
N0+N1 101 32(31.7%) 15(14.9%) 0.979 24(23.8%) 30(29.7%) 0.105
N2+N3 51 13(25.5%) 6(11.8%)   20(39.2%) 12(23.5%)  
Histology-differentiation        
Well 51 15(29.4%) 11(21.6%) 0.123 11(21.6%) 14(27.5%) 0.395
Poorly 101 31(30.7%) 10(9.9%)   33(32.7%) 28(27.7%)  
  1. a x2 test
  2. b median age